Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dividend investing for retirement -- Ignore unavailable to you. Want to Upgrade?

To: JimisJim who wrote (13967)	1/28/2013 12:33:42 AM
From: Mannie	Respond to of 34328

I must be doing something wrong. I own exactly one of the stocks (SRE) mentioned in that article you have me beat! One there I am looking to add, WEC.

To: JimisJim who wrote (13967)	1/28/2013 12:43:08 AM
From: Paul Senior	Respond to of 34328

What struck me was that for a "low beta" portfolio, 14 of the 30 stocks were at or very close to their 12-mo highs. Those would be stocks I would now not want to enter, if I wanted low beta and might be worried about a market correction. I have a few of the stocks on the list, and I looked at the others. One that I believe might be suitable for me is NTT, and I've placed an order for a few shares. Jmo, and I've been wrong many, many times.

To: JimisJim who wrote (13967)	1/28/2013 6:47:38 AM
From: Ditchdigger	Read Replies (2) \| Respond to of 34328

Looking at the sector rotation model, I've decided to get ahead of the curve and add another big pharma stock. So I'm looking for nominees , opinions? (I'm still holding LLY) Looking further out on the model (currently holding a fair share of inds. & materials) and probably far to early, I added a few shares of SO last week after finally selling PBCT. PBCT was a disappointment, break even after holding for a year.They just don't seem to be able to get their ducks in a row. ditch